<DOC>
	<DOCNO>NCT00532454</DOCNO>
	<brief_summary>Primary objective study evaluate effect CYP2D6 genotype time progression tamoxifen treatment pre- postmenopausal woman metastatic breast cancer . Furthermore , evaluate effect CYP2D6 genotypes clinical benefit response duration tamoxifen administration pre- postmenopausal woman metastatic breast cancer also evaluate effect CYP2D6 genotype steady state plasma concentration tamoxifen metabolite</brief_summary>
	<brief_title>Evaluation Association Between CYP2D6 Genetic Polymorphisms Treatment Effect Tamoxifen</brief_title>
	<detailed_description />
	<mesh_term>Breast Neoplasms</mesh_term>
	<mesh_term>Neoplasm Metastasis</mesh_term>
	<mesh_term>Tamoxifen</mesh_term>
	<criteria>Histologically cytologically diagnose stage IV recurrent breast cancer patient accord American Joint Committee Cancer ( AJCC ) Positive estrogen receptor Positive progesterone receptor . Females least 18 year age . Prior radiation therapy allow long irradiated area source measurable disease Prior hormone therapy less 2 . No history Megace medication recent 28 day Performance status 0 , 1 2 ECOG criterion Clinically measurable disease , define bidimensionally measurable lesion clearly define margin xray , CT scan , MRI physical examination . Lesions serve measurable disease must east 1 cm 1 cm , define xray , CT scan , MRI , physical examination Bone pleural fluid disease include long evaluation clinical benefit possible Estimated life expectancy least 12 week Compliant patient followedup adequately . Adequate hematologic ( WBC count 3,000/mm3 , platelet count 100,000/mm3 ) , hepatic ( bilirubin level 1.8 mg/dL , AST , ALT 1.5xULN , albumin 2.5 g/dL ) , renal ( creatinine concentration 1.5 mg/dL ) function . Informed consent patient patient 's relative Childbearing woman use nonhormonal contraceptive method Active uncontrolled infection . Second primary malignancy ( except situ carcinoma cervix adequately treat basal cell carcinoma skin prior malignancy treat 5 year ago without recurrence ) .</criteria>
	<gender>Female</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>September 2007</verification_date>
</DOC>